Degree-Based Molecular Descriptors and QSPR Analysis of Breast Cancer Drugs

Figure 1

Molecular structures of breast cancer drugs. (a) Alpelisib. (b) Azacitidine. (c) Cytarabine. (d) Daunorubicin. (e) Dexamethasone. (f) Docetaxel. (g) Doxorubicin. (h) Glasdegib. (i) Gilteritinib. (j) Ivosidenib. (k) Midostaurin. (l) Olaparib. (m) Paclitaxel. (n) Palbociclib. (o) Pamidronic acid. (p) Prednisone. (q) Ribociclib. (r) Tioguanine. (s) Toremifene. (t) Tucatinib. (u) Venetoclax.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)

(t)

(u)